Results
1
1 companies
argenx
Market Cap: €43.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€717.60
7D
2.1%
1Y
16.5%
